Hikari to Kage
Hikari to Kage (光と影, "Light and Shadow") is Japanese singer songwriter Fayray's seventh studio album.[1] The album was released on January 25, 2006.[1]
Hikari to Kage | ||||
---|---|---|---|---|
![]() | ||||
Studio album by | ||||
Released | January 25, 2006 | |||
Recorded | 2005 | |||
Genre | Pop | |||
Length | 48:57 | |||
Label | R and C | |||
Producer | Fayray | |||
Fayray chronology | ||||
| ||||
Singles from Hikari to Kage | ||||
|
The total length of this album is 48:57, and it peaked at number 40.
Track listing
No. | Title | Lyrics | Music | Length |
---|---|---|---|---|
1. | "Home" | Fayray | Fayray | 4:52 |
2. | "Pain" | Fayray | Fayray | 4:18 |
3. | "Close Your Eyes" | Fayray | Fayray | 4:55 |
4. | "Nostalgia" | Fayray | Fayray, Marc Ribot, Dougie Bowne | 4:47 |
5. | "Hikari to Kage" (光と影 "Light and Shadow") | Fayray | Fayray | 4:17 |
6. | "Nami" (波 "Wave") | Fayray | Fayray | 5:39 |
7. | "Spotlight" | Fayray | Fayray | 4:59 |
8. | "Shame" | Fayray | Fayray, Ribot, Bowne | 3:46 |
9. | "Angel" | Fayray | Fayray | 5:49 |
10. | "Ai Sansan" (愛燦燦) | Kei Ogura | Ogura | 5:11 |
Total length: | 48:57 |
Charts and sales
Chart (2006) | Peak position |
Sales |
---|---|---|
Japan Oricon Weekly Albums Chart[2] | 40 | 8,674 |
gollark: It isn't. The actual number of cases is independent of how many you know about.
gollark: I, for one, am using my atoms for nonpaperclip purposes and somewhat need them.
gollark: So you're arguing that the marginal value of a vaccine to everyone isn't great because it does not get substantially closer to eradication?
gollark: And?
gollark: The effectiveness in general scales with how many people have it and how good the vaccines are individually. We want to maximize that. So... it's sensible to reduce one factor because the other is lower?!
References
- "FAYRAY、全国ツアーに先立ちインストア・イベント開催". Barks (in Japanese). January 25, 2009. Retrieved April 19, 2010.
- "Fayrayがクリムゾンのムーンチャイルドをカバー" (in Japanese). Retrieved April 19, 2010.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.